EMAIL THIS PAGE TO A FRIEND

Biomaterials

Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice.


PMID 26142777

Abstract

Subcutaneous liver tissue engineering is an attractive and minimally invasive approach used to curative treat hepatic failure and inherited liver diseases. However, graft failure occurs frequently due to insufficient infiltration of blood vessels (neoangiogenesis), while the maintenance of hepatocyte phenotype and function requires inxa0vivo development of the complex cellular organization of the hepatic lobule. Here we describe a subcutaneous human liver construction allowing for rapidly vascularized grafts by transplanting engineered cellular sheets consisting of human primary hepatocytes adhered onto a fibroblast layer. The engineered hepatocyte/fibroblast sheets (EHFSs) showed superior expression levels of vascularization-associated growth factors (vascular endothelial growth factor, transforming growth factor beta 1, and hepatocyte growth factor) inxa0vitro. EHFSs developed into vascularized subcutaneous human liver tissues contained glycogen stores, synthesized coagulation factor IX, and showed significantly higher synthesis rates of liver-specific proteins (albumin and alpha 1 anti-trypsin) inxa0vivo than tissues from hepatocyte-only sheets. The present study describes a new approach for vascularized human liver organogenesis under mouse skin. This approach could prove valuable for establishing novel cell therapies for liver diseases.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1306569
ANTI-CYK18(C-TERMINAL) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4501665
Anti-Keratin 18, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4300551
Anti-KRT18 (Ab-33) antibody produced in rabbit, affinity isolated antibody
AV40205
Anti-KRT18 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV40206
Anti-KRT18 (AB2) antibody produced in rabbit, IgG fraction of antiserum
GW22753 Anti-KRT18 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2701928
Anti-krt18 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3701079 Anti-Mouse IgG (H+L) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3701163 Anti-Mouse IgG (H+L), F(ab) fragment antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
F9137 Anti-Mouse IgG (whole molecule)−FITC antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3700999 Anti-Mouse IgG F(ab′)2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3701000 Anti-Mouse IgG F(ab′)2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
E2761
ExtrAvidin®−FITC, buffered aqueous solution
E3011 ExtrAvidin®−TRITC, buffered aqueous solution
SAB3300015
Monoclonal Anti-CK18 antibody produced in mouse, clone 10, purified immunoglobulin, buffered aqueous glycerol solution
SAB3300017 Monoclonal Anti-CK18 antibody produced in mouse, clone 1H10, purified immunoglobulin, buffered aqueous glycerol solution
SAB1305526
MONOCLONAL ANTI-CYK18 (C-TERMINAL) antibody produced in mouse, clone 695CT17.2.6, crude ascites, buffered aqueous solution
SAB1305562
MONOCLONAL ANTI-CYK18(C-TERMINAL) antibody produced in mouse, clone 695CT17.2.6, IgG fraction of antiserum, buffered aqueous solution
WH0003875M1
Monoclonal Anti-KRT18 antibody produced in mouse, clone 2F8, purified immunoglobulin, buffered aqueous solution
SAB1404012
Monoclonal Anti-KRT18 antibody produced in mouse, clone 1G8, purified immunoglobulin, buffered aqueous solution
SAB4700411
Monoclonal Anti-KRT18 antibody produced in mouse, clone C-04, purified immunoglobulin, buffered aqueous solution
SAB4700670 Monoclonal Anti-KRT18 antibody produced in mouse, clone DC-10, purified immunoglobulin, buffered aqueous solution